Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
- Reuters
Cantor Fitzgerald analyst Sarah James reiterates Progyny (NASDAQ:PGNY) with a Overweight and maintains $37 price target.
JP Morgan analyst Anne Samuel maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $41 to $31.
BTIG analyst David Larsen downgrades Progyny (NASDAQ:PGNY) from Buy to Neutral.
JMP Securities analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and lowers the price tar...
Cantor Fitzgerald analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $48...
Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $37 to...
